Advanced Technology Infrastructure and GMP Standards
Eliz Pharmaceuticals’ Clinical R&D infrastructure is supported by ISO Class cleanroom environments that ensure maximum sterility assurance, a fully validated equipment fleet, and laboratories specifically designed for pharmaceutical product development.
The Clinical R&D infrastructure of Eliz Pharmaceuticals is reinforced with ISO Class cleanroom conditions that provide the highest level of sterility safety, a fully validated device inventory, and specialized laboratories for pharmaceutical formulation and development.
Technologies in use include:
-
Modern WFI (Water for Injection) systems
-
Compounding units and fully automated production lines
-
High-precision analytical systems such as HPLC, GC, and ICP-MS
-
Microbiology and physicochemical laboratories
-
Validation & calibration laboratories
-
PP/PE packaging development and barrier-test units
This infrastructure ensures the physicochemical stability and microbiological safety of our products.
Patient Safety and Ethical Standards First
Our Clinical Research and Development processes are conducted in strict adherence to ethical principles that place human health at the center.
All clinical studies are carried out in full compliance with:
-
The Declaration of Helsinki
-
GCP (Good Clinical Practice)
-
ICH safety guidelines
-
Turkish Pharmacovigilance Regulations
Every product undergoes multi-stage clinical safety evaluations before reaching patients.
